COVID-19 patients have been shown to have relatively low CD73 levels on cytotoxic lymphocyte populations including CD8+T, natural killer T (NKT) and natural killer (NK) cells (183) and several such abnormal phenotypes may contribute to an uncoupling between the innate and adaptive immune system in patients experiencing progressive COVID-19 (184). The gene discussed is NT5E; the disease is COVID-19.